T1	Participants 98 146	postmenopausal women with advanced breast cancer
T2	Participants 149 270	Eighty-eight postmenopausal women with metastatic breast cancer, in whom estrogen receptors (ER) were positive or unknown
T3	Participants 1172 1223	postmenopausal patients with advanced breast cancer
T4	Participants 512 568	Patients with known ER negative status were not studied.
